Qiagen N.V. (QGEN)
Qiagen N.V. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Qiagen N.V. (QGEN) is a Medical - Diagnostics & Research company based in NL with a market capitalization of $7.6B. Revenue grew 5.7% year-over-year and the company generated $453.3M in free cash flow. This page tracks QGEN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
NL · 5.7K employees · IPO Jun 28, 1996
Valuation
Valuation & price
$32.98as of May 17, 2026· -40.7% vs 52w high
16.1
P/E ratio
Latest-FY diluted EPS
2.01
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$7.6B
Market cap
5.7%
Revenue growth (YoY)
61.8%
Gross margin
$453.3M
Free cash flow (USD)
$555.5M
Net debt
-3.9%
Share dilution
3/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 6-K filed May 8, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Qiagen N.V.'s market cap?
Qiagen N.V. (QGEN) has a market capitalization of $7.6B.
What is QGEN's P/E ratio?
QGEN trades at a price-to-earnings ratio of 16.1, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is QGEN's price-to-book (P/B) ratio?
QGEN trades at 2.01 times book value per share.
Are insiders buying QGEN stock?
SEC Form 4 filings show no open-market insider buys at Qiagen N.V. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Diagnostics & Research
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.